Depression and Anxiety Trial, Recruiting NCT07186023 Sponsor: National Health Research Institutes, Taiwan Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07186023
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the mindfulness-based part of the trial:

  • People who can read and write, or who have completed more than a basic level of schooling.
  • People who have normal vision and hearing, or who use glasses or hearing aids that fully correct these, and who are able to communicate and understand instructions.
  • People who are right-handed, as confirmed by a standard handedness checklist called the Edinburgh Handedness Inventory.

For the brain stimulation part of the trial:

  • People who have been diagnosed with major depressive disorder by a psychiatrist, using standard diagnostic guidelines, and who are able to follow outpatient clinic rules and routines.
  • People who can read and write, or who have completed more than a basic level of schooling.
  • People who have normal vision and hearing, or who use glasses or hearing aids that fully correct these, and who are able to communicate and understand instructions.
  • People who are right-handed, as confirmed by a standard handedness checklist called the Edinburgh Handedness Inventory.
  • People for whom a clinical doctor has prescribed brain stimulation therapy.

Who may not be able to join:

For both parts of the trial:

  • People who have dementia, have had a stroke, have blood vessel disease affecting the brain, a brain injury, epilepsy, or Parkinson's disease.
  • People who have any other disorder affecting the nervous system (confirm with trial site).
  • People who are dependent on alcohol or drugs.
  • People who have other serious physical health conditions, such as diabetes, heart failure, or hormone/gland disorders, or who have had a heart attack in the past three months.
  • People who have metal objects inside their body that would prevent them from having an MRI scan — for example, a heart pacemaker, vascular clips, hearing implants, artificial joints, or metal pins.
  • People who have claustrophobia (fear of enclosed spaces), which could make MRI scanning difficult.
  • People who are pregnant or who may possibly be pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-5-6327369

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Health Research Institutes, Taiwan
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 May 2028

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Changes in neural activation related to emotional processing, sensory processing, attention, and memory-related brain regions.; Changes in resting-state functional connectivity within and between brain networks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov